Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
November 25, 2024 09:30 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.
Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis for the Nine Months Ended 30 September 2024
November 21, 2024 02:00 ET
|
Cornish Metals Inc.
Cornish Metals released its unaudited financial statements and management, discussion and analysis (“MD&A”) for the nine months ended September 30, 2024.
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 12, 2024 16:05 ET
|
Fractyl Health, Inc.
REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
November 07, 2024 16:05 ET
|
Assembly Biosciences, Inc.
Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, supporting potential for once-weekly and once-monthly oral...
Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%
November 07, 2024 02:02 ET
|
Novonesis (Novozymes A/S)
Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong...
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
October 29, 2024 07:00 ET
|
Fractyl Health, Inc.
BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes...
Orezone Provides Notice of Q3-2024 Results and Conference Call
October 28, 2024 14:03 ET
|
Orezone Gold Corporation
VANCOUVER, British Columbia, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its third quarter 2024 results on November 5, 2024, after...
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
October 28, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
CSX Corporation Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
October 21, 2024 16:50 ET
|
Block & Leviton LLP
Block & Leviton is investigation CSX Corp. for potential securities law violations. Investors who lost money in CSX should contact the firm to learn more.
Laser Photonics Corp. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
October 01, 2024 11:56 ET
|
Block & Leviton LLP
Block & Leviton is investigating Laser Photonics Corp (Nasdaq: LASE) for potential securities fraud. Investors who have lost money should contact the firm.